Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

The effect of smoking on mortality risk in RA patients – a 36-year follow-up

Posted by on May 25, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the effect of smoking habits on mortality rates in women with rheumatoid arthritis (RA) over 36 years. The authors concluded that women who quit smoking entirely within 4 years of diagnosis of RA had reduced mortality rates. RA patients who smoked more and for longer were at a significantly higher risk of mortality...

Read More

MRI scans can detect silent progression of rheumatoid arthritis in patients considered in remission

Posted by on May 14, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The study looked at increases in bone erosion and swelling using body imaging scans in patients with rheumatoid arthritis that were in remission. The authors concluded that up to 40% of patients in remission showed increases in bone erosion. Some background In rheumatoid arthritis (RA) patients experience inflammation and pain in...

Read More

Can light-intensity exercise reduce cardiovascular risk in patients with rheumatoid arthritis?

Posted by on Apr 25, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the role of physical activity in rheumatoid arthritis (RA). The authors concluded that patients with RA are mostly active at light intensities. Light physical activity was found to reduce cardiovascular risk and also improved RA outcomes.  Some background Patients with rheumatoid arthritis (RA) can experience...

Read More

Biological drug treatments for rheumatoid arthritis – an update

Posted by on Apr 16, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined data from a number of recent studies to assess biological drug treatment for rheumatoid arthritis (RA). The authors concluded that the results confirmed the effectiveness of biological drugs in treating RA. Some background Disease-modifying anti-rheumatic drugs (DMARDs) is a category of drugs defined by their use...

Read More

Anti-TNF therapy: Predictors of success

Posted by on Mar 15, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The study examined predictors of treatment success with anti-TNF drugs for rheumatoid arthritis (RA). The authors concluded that immune response and the presence of a protein in the blood can predict treatment outcomes with anti-TNF drugs. Some background In rheumatoid arthritis (RA), the immune system attacks the healthy joints the...

Read More

Examining the presence of RA in patients with and without the presence of certain antibodies in the blood

Posted by on Mar 14, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the severity of inflammation in rheumatoid arthritis (RA) patients with (seropositive) and without (seronegative) certain antibodies in their blood. The authors concluded that seronegative patients had higher levels of inflammation than seropositive patients. Some background RA is diagnosed based on a number of...

Read More

What is next for RA patients who have not responded to conventional treatment?

Posted by on Feb 8, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of two different treatments in rheumatoid arthritis (RA) patients who have not responded well to conventional treatment with disease-modifying anti-rheumatic drugs (DMARDs). The authors concluded that changing to a biological drug showed better remission rates than switching to an alternative...

Read More